Abstract
Given the almost limitless variety of nanomaterials, it will be virtually impossible to assess the possible occupational health hazard of each nanomaterial individually. The development of science-based hazard and risk categories for nanomaterials is needed for decision-making about exposure control practices in the workplace. A possible strategy would be to select representative (benchmark) materials from various mode of action (MOA) classes, evaluate the hazard and develop risk estimates, and then apply a systematic comparison of new nanomaterials with the benchmark materials in the same MOA class. Poorly soluble particles are used here as an example to illustrate quantitative risk assessment methods for possible benchmark particles and occupational exposure control groups, given mode of action and relative toxicity. Linking such benchmark particles to specific exposure control bands would facilitate the translation of health hazard and quantitative risk information to the development of effective exposure control practices in the workplace. A key challenge is obtaining sufficient dose–response data, based on standard testing, to systematically evaluate the nanomaterials’ physical–chemical factors influencing their biological activity. Categorization processes involve both science-based analyses and default assumptions in the absence of substance-specific information. Utilizing data and information from related materials may facilitate initial determinations of exposure control systems for nanomaterials.
Similar content being viewed by others
Notes
A benchmark dose (BMD) is the dose associated with a specified increase (e.g., 10 %) in the probability of a given response known as the benchmark response (BMR) (Crump 1984). The BMD is a maximum likelihood estimate, and the BMDL is the 95 % LCL of the BMD.
A critical effect level of 0.1 % excess risk of lung cancer is estimated in this example by linear extrapolation of the 10 % BMD and BMDL estimates. The BMD(L) estimates are based on lung burden at the end of the two-yr exposure if those data were available or on airborne exposure concentration otherwise.
For those particles with 2-yr rat lung burden data, the rat critical lung dose (as particle mass or surface area dose per g lung) was converted to mg/lung to use as the target lung dose in a human lung dosimetry model (assuming average worker lung weight of 1000 g) (ICRP 1975) (CIIT and RIVM 2006). For those particles without 2-yr rat lung burden data, the deposited daily dose (mg/d) was calculated by accounting for the species differences in ventilation rates and alveolar deposition fractions (Kuempel et al. 2006).
Human-equivalent 45-yr working lifetime concentrations were estimated in a human lung dosimetry model (CIIT and RIVM 2006) for those particles with rat lung burden data. For those particles without rat lung burden data, the human 8-hr TWA concentrations were estimated by adjusting for the species differences in the alveolar surface area (102 m2 human/0.4 m2 rat), particle size-specific deposition fraction, and ventilation (assuming reference worker rate of 9.6 m3/8-hr d) (ICRP 1994) (Kuempel et al. 2006).
The greater tumor potency of Ni3S2 compared to NiO may be due to oxidative DNA damage (8-OH-dG), which was observed in cultured cells treated with Ni3S2, but not in cells treated with NiO or NiSO4 (Kawanishi et al. 2002).
References
ACGIH (2008) Gallium arsenide. In: Threshold limit values for chemical substances and physical agents and biological exposure indices. American Conference of Governmental Industrial Hygienists, Cincinnati, p 12
Ader AW, Farris JP, Ku RH (2005) Occupational health categorization and compound handling practice systems: roots, application and future. Chem Health Safety, July/Aug:20–24
ANSES (2010) Development of a specific control banding tool for nanomaterials. Agence nationale de sécurité sanitarie, Maisons-Alfort Cedex
Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman DT (2012) The diesel exhaust in miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer Inst, 104(11):869–883
BSI (2007) Nanotechnologies, Part 2. PD 6699-2:2007: guide to safe handling and disposal of manufactured nanomaterials. British Standards Institution, London
Castranova V (2000) From coal mine dust to quartz: mechanisms of pulmonary pathogenicity. Inhal Toxicol 3:7–14
Castranova V (2011) Overview of current toxicological knowledge of engineered nanoparticles. JOEM 53(6 Suppl):S14–S17
CFR (2001) Limit on exposure to diesel particulate matter, Mine Safety and Health Administration. Code of federal regulations: 30 CFR Section 57.5060. US Government Printing Office, Office of the Federal Register, Washington, DC
CIIT, RIVM (2006) Multiple-path particle dosimetry (MPPD V 2.0): a model for human and rat airway particle dosimetry. Research Triangle Park, NC, USA: Centers for Health Research (CIIT) and the Netherlands: National Institute for Public Health and the Environment (RIVM)
Crump KS (1984) A new method for determining allowable daily intakes. Fund Appl Toxicol 4:854–871
Dolan DG, Naumann BD, Sargent EV, Maier A, Dourson M (2005) Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations. Regul Toxicol Pharmacol 43:1–9
Donaldson K, Borm PJ, Oberdörster G, Pinkerton KE, Stone V, Tran CL (2008) Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal Toxicol 20:53–62
Donaldson K, Murphy FA, Duffin R, Poland CA (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 22(7):5
Driscoll KE (1996) Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. In: Mauderly JL, McCunney RJ (eds) Particle overload in the rat lung and lung cancer: implications for human risk assessment. Taylor & Francis, Philadelphia, pp 139–152
Duffin R, Tran L, Brown D, Stone V, Donaldson K (2007) Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19(10):849–856
Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdörster G (2005) Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 88(2):614–629
Grieger KD, Linkov I, Hansen SF, Baun A (2012) Environmental risk analysis for nanomaterials: review and evaluation of frameworks. Nanotoxicol 6(2):196–212
Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K (1995) Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal Toxicol 7:533–556
Hewett P, Logan P, Mulhausen J, Ramachandran G, Banerjee S (2006) Rating exposure control using Bayesian decision analysis. J Occup Environ Hyg 3:568–581
ICRP (1975) Report of the task group on reference man: a report prepared by a task group of committee 2 of the International Commission on Radiological Protection. Pergamon, Elmsford
ICRP (1994) Human respiratory tract model for radiological protection. International commission on radiological protection publication no. 66. Elsevier, Oxford
Invernizzi N (2011) Nanotechnology between the lab and the shop floor: what are the effects on labor? J Nanopart Res. doi:10.1007/s11051-011-03033-z
Jones RM, Nicas M (2006) Margins of safety provided by COSHH essentials and the ILO chemcial control toolkit. Ann Occup Hyg 50(2):149–156
Kuempel ED, Tran CL, Castranova V, Bailer AJ (2006) Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol 18(10):717–724
Kuempel ED, Geraci CL, Schulte PA (2007) Risk assessment approaches and research needs for nanoparticles: an examination of data and information from current studies. Proceedings of the NATO Advanced Research Workshop on Nanotechnology: Toxicological Issues and Environmental Safey, Varna, Bulgaria, August 12–17, 2006. In: Simeonova P, Opopol N, Luster M (eds) Nanotechnology: toxicological issues and environmental safety. Springer, New York, pp 119–145
Kuempel ED, Smith RJ, Dankovic DA, Stayner LT (2009) Rat- and human-based risk estimates of lung cancer from occupational exposure to poorly-soluble particles: a quantitative evaluation. J Phys Conf Series 151:012011
Lee KP, Trochimowicz HJ, Reinhardt CF (1985) Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for 2 years. Toxicol Appl Pharmacol 79:179–192
Linkov I, Satterstrom FK, Steevens J, Ferguson E, Pleus RC (2007) Multi-criteria decision analysis and environmental risk assessment for nanomaterials. J Nanopart Res 9(4):543–554
Linkov I, Steevens J, Adlakha-Hutcheon F, Bennett E, Chappell M, Colvin V, Davis M, Davis T, Elder A, Hansen SF, Hakkinen PB, Hussain SM, Karkan D, Korenstein R, Lynch I, Metcalfe C, Ramadan AB, Satterstrom FK (2009) Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO advanced research workshop. J Nanopart Res 11:513–527
Mauderly JL (1997) Relevance of particle-induced rat lung tumors for assessing lung carcinogenic hazard and human lung cancer risk. Environ Health Perspect 105(Suppl 5):1337–1346
Maynard AD (2007) Nanotechnology: the next big thing, or much ado about nothing? Ann Occup Hyg 51(1):1–12
Maynard AD, Kuempel E (2005) Airborne nanostructured particles and occupational health. J Nanoparticle Res 7(6):587–614
Melnick RL, Bucher JR, Roycroft JH, Hailey JR, Huff J (2003) Carcinogenic and toxic effects of inhaled, nonfibrous, poorly soluble particulates in rats and mice contradict threshold lung cancer hypotheses that are dependent on chronic pulmonary inflammation. Eur J Oncol 8(3):177–186
Morrow PE (1988) Possible mechanisms to explain dust overloading of the lungs. Fund Appl Toxicol 10(3):369–384
Muhle H, Bellmann B, Creutzenberg O, Dasenbrock C, Ernst H, Kilpper R, MacKenzie JC, Morrow P, Mohr U, Takenaka S, Mermelstein R (1991) Pulmonary response to toner upon chronic inhalation exposure in rats. Fund Appl Toxicol 17:280–299
Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D (2005) Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207(3):221–231
Murray AR, Kisin ER, Tkach AV, Yanamala N, Mercer R, Young S-H, Fadeel B, Kagan VE, Shvedova AA (2012) Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Particle Fibre Toxicol 9:10
Nakanishi J (2011) Risk Assessment of Manufactured Nanomaterials: Carbon Nanotubes (CNT). Final report issued on August 12, 2011. New Energy and Industrial Technology Development Organization (NEDO) project (P06041) "Research and Development of Nanoparticles Characterization Methods." National Institute of Advanced industrial Science and Technology (AIST). Available at http://www.aist-riss.jp/main/?ml_lang=en
Naumann BD, Sargent EV, Starkman BS, Fraser WJ, Becker GT, Kirk GD (1996) Performance-based exposure control limits for pharmaceutical active ingredients. Am Ind Hyg Assoc J 57:33–42
Nikula KJ, Snipes MB, Barr EB, Griffith WC, Henderson RF, Mauderly JL (1995) Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol 25:80–94
NIOSH (2005) NIOSH pocket guide to chemical hazards and other databases. DHHS (NIOSH) Publication No. 2005-149. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati
NIOSH (2010a) Strategic plan for NIOSH nanotechnology research and guidance filling the knowledge gaps. DHHS (NIOSH) Publication No. 2010–105. U.S. Department of Health and Human Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati
NIOSH (2010b) Current intelligence bulletin: occupational exposure to carbon nanotubes and nanofibers. Draft for public comment. NIOSH Docket Number: NIOSH 161-A. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati
NIOSH (2011) Current intelligence bulletin 63: occupational exposure to titanium dioxide. NIOSH (DHHS) Publication No. 2011-160. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati
NRC (2009) Science and decisions: advancing risk assessment. Committee on improving risk analysis approaches used by the U.S. EPA, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council of the National Academies
NTP (1996–2000) National Toxicology Program, Technical Report Series: Toxicology and carcinogenesis in F344/N rats and B6C3F1 mice (inhalation studies). US Department of Health and Human Services, National Institutes of Health (NIH), Research Triangle Park, NC. Reports referenced include: Cobalt sulfate heptahydrate (NIH 1998, Pub. No. 98-3961, NTP TR 471); gallium arsenide (NIH 2000, Pub. No. 00-3951, NTP TR 492); nickel oxide (NIH 1996, Pub. No. 96-3367, NTP TR 451); nickel subsulfide (NIH 1996, Pub. No. 96-3369, NTP TR 453); and molybdenum trioxide (NIH 1997, Pub. No. 97-3378, NTP TR 462)
Oberdörster G, Yu CP (1990) The carcinogenic potential of inhaled diesel exhaust: a particle effect? J Aerosol Sci 21(Suppl 1):S397–S401
Oberdörster G, Ferin J, Lehnert BE (1994) Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102(Suppl 5):173–179
Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005a) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Report of the international life sciences institute research foundation/risk science institute nanomaterial toxicity screening working group. Part Fibre Toxicol 2:8
Oberdörster G, Oberdörster E, Oberdörster J (2005b) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839
OECD (2007) Guidance on grouping of chemicals. Series on testing and Assessment, No. 80. ENV/JM/MONO(2007)28 Organization for Economic Cooperation and Development, Environmental Health and Safety Publications
OECD (2010a) List of manufactured nanomaterials and list of endpoints for phase one of the sponsorship programme for the testing of manufactured nanomaterials: revision. No. 27. ENV/JM/MONO(2010)46. Organization for Economic Cooperation and Development, Series on the Safety of Manufactured Nanomaterials
OECD (2010b) Guidance manual for the testing of manufactured nanomaterials: OECD’s sponsorship programme; first revision. ENV/JM/MONO(2009)20/REV
Pauluhn J (2010) Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci 113(1):226–242
Pauluhn J (2011) Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology 279(1–3):176–188
Rom WN, Markowitz S (2006) Environmental and occupational medicine. Lippincott Williams & Wilkins, Philadelphia
Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, Elder A, Han X, Gelein R, Finkelstein J, Oberdorster G (2010) Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A 73:445–461
Sargent LM, Shvedova AA, Hubbs AF, Salisbury JL, Benkovic SA, Kashon ML, Lowry DT, Murray AR, Kisin ER, Friend S, McKinstry KT, Battelli L, Reynolds SH (2009) Induction of aneuploidy by single-walled carbon nanotubes. Environ Mol Mutagen 50(8):708–717
Sargent LM, Hubbs AF, Young SH, Kashon ML, Dinu CZ, Salisbury JL, Benkovic SA, Lowry DT, Murray AR, Kisin ER, Siegrist KJ, Battelli L, Mastovich J, Sturgeon JL, Bunker KL, Shvedova AA, Reynolds SH (2011b) Single-walled carbon nanotube-induced mitotic disruption. Mutat Res 745(1–2):28–37
Schoeny RS, Margosches E (1989) Evaluating comparative potencies: developing approaches to risk assessment of chemical mixtures. Toxicol Indust Health 5(5):825–837
Schulte PA, Salamanca-Buentello F (2007) Ethical and scientific issues of nanotechnology in the workplace. Environ Health Perspect 115(1):5–12
Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E (2008) Occupational risk management of engineered nanoparticles. JOEH 5:239–249
Schulte PA, Murashov V, Zumwalde R, Kuempel ED, Geraci CL (2010) Occupational exposure limits for nanomaterials: state of the art. J Nanopart Res 12:1971–1987
Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P (2005) Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698–L708
Sobels FH (1993) Approaches to assessing genetic risks from exposure to chemicals. Environ Health Perspect 101(Suppl 3):327–332
Stayner L, Kuempel E, Gilbert S, Hein M, Dement J (2008) An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med 65(9):613–619
Stefaniak AB, Virji MA, Day GA (2011) Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid. Chemosphere 83(8):1181–1187
Sutter JR (1995) Molecular and cellular approaches to extrapolation for risk assessment. Environ Health Perspect 103:386–389
Tervonen T, Linkov I, Figueira FR, Steevens J, Chappell M, Merad M (2009) Risk-based classification system of nanomaterials. J Nanopart Res 11:757–766
Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K (2000) Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 12(12):1113–1126
U.S. EPA (1987) Recommendations for and documentation of biological values for use in risk assessment. Environmental criteria and assessment office, office of health and environmental assessment, office of research and development, U.S. Environmental Protection Agency, August, Cincinnati
U.S. EPA (2010) Benchmark dose software, version 2.1.2. U.S. Environmental Protection Agency, National Center for Environmental Assessment, Washington
U.S. Supreme Court (1980) Industrial Union Department, AFL-CIO v. American Petroleum Institute et al., Case Nos. 78-911, 78-1036. Supreme Court Reporter 100:2844–2905
Wang L, Mercer RR, Rojanasakul Y, Qiu A, Lu Y, Scabilloni JF, Wu N, Castranova V (2010) Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health Part A 73(5):410–422
Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM (2007) Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 171:99–110
Zalk DM, Nelson DI (2008) History and evolution of control banding: review. J Occup Environ Hyg 5:330–346
Zalk DM, Paik SY, Swuste P (2009) Evaluating the control banding nanotool: a qualitative risk assessment method for controlling nanoparticle exposures. J Nanopart Res 11:1685–1704
Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, Pokhrel S, Lin s, Wang X, Liao YP, Wang M, Li L, Rallo R, Damoiseaux R, Telesca D, Mädler L, Cohen Y, Zink JI, Nel AE (2012) Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 6(5):4349–4368
Acknowledgement
We would like to thank Mr. Randall Smith for helpful discussions concerning statistical aspects of this paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Special Issue Editors: Candace S.-J. Tsai, Michael J. Ellenbecker
Disclaimer
The findings and conclusion in this paper are those of the authors and do not necessarily represent the view of the National Institute for Occupational Safety and Health.
This article is part of the Topical Collection on Nanotechnology, Occupational and Environmental Health
Rights and permissions
About this article
Cite this article
Kuempel, E.D., Castranova, V., Geraci, C.L. et al. Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res 14, 1029 (2012). https://doi.org/10.1007/s11051-012-1029-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-012-1029-8